See the Glossary for more terms.
Concepts represent early planning stages for program announcements, request for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to the Opportunities and Announcements portal.
NB: Council approval does not guarantee that a concept will become an initiative.
For the published request for applications, see the February 3, 2014, Guide announcement.
Request for Applications
Contact: James McNamara
Objective: To recompete the biostatistical, data management, and clinical trial operations awards as a comprehensive and consolidated project that supports clinical research studies and trials in allergy and asthma, autoimmunity, and transplantation.
Description: The DAIT Statistical and Clinical Coordinating Center will provide complete biostatistical and operational support for clinical trials in the area of allergy and asthma, autoimmune diseases, and transplantation. Research consortia currently being supported through separate awards include:
Support for consortia and other clinical trials supported by the Division will include: 1) statistical leadership for the design and analysis of clinical trials, including periodic safety and administrative reports, data and safety monitoring board reports, and final analyses and reports; 2) data collection, management, and quality assurance programs; 3) clinical site monitoring and training; 4) pharmacovigilance, including serious adverse event data collection, evaluation, and report preparation; 5) distribution and quality control of study products; and 6) support for technical and administrative functions of the clinical trial consortia.
Contact: Jeffrey Rice
Objective: The goal of the HLA Region Genomics in Immune-Mediated Diseases program is to define the association between variations in human leukocyte antigen (HLA) and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including risk and severity of disease, and organ, tissue, and cell transplantation outcomes. The program will continue to generate high-quality HLA- and KIR-disease association data, correlated with patient phenotypes that will be submitted to publically accessible databases.
Description: This program will support retrospective or prospective studies to investigate the relationship between genetic variation in the HLA region and immune-mediated diseases. Areas of research may include:
No changes were made in the scope or mechanism of the support activities.
Last Updated February 03, 2014
Last Reviewed February 03, 2014